Collegium Pharmaceutical, Inc. COLL Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Collegium Pharmaceutical, Inc. (COLL) reported accretion (amortization) of discounts and premiums, investments of $178K in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Collegium Pharmaceutical, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 45.1% year-over-year, from $324K to $178K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- The periodic adjustment to the carrying value of investment securities to reflect the amortization of premiums or accretion of discounts. This non-cash adjustment aligns the investment's book value with its expected redemption value over time.